Share this article and save a life!
90 seconds to know if your brain tumor surgery worked.
That’s all it takes now.
University of Michigan just changed brain cancer surgery forever with DeepGlioma, an AI that reads tumor genetics while you’re still on the operating table.
Here’s why this matters:
Gliomas kill. Median survival for these aggressive brain tumors? Just 18 months. Every second of surgery counts, every millimeter of tumor removed matters.
But surgeons have been operating blind.
They couldn’t know the tumor’s genetic makeup during surgery. They’d remove what they could see, close up, wait days for pathology, then discover they missed critical tissue or removed too much healthy brain.
Not anymore.
🧠 DeepGlioma analyzes tissue in real-time using stimulated Raman histology
🧠 Predicts genetic mutations that determine treatment paths
🧠 Guides surgeons to remove more tumor, preserve more brain
The companion tool, FastGlioma, goes even further: 10 seconds to detect residual tumor tissue. Trained on 11,000 specimens. Outperforming standard methods.
Think about that impact:
• More complete tumor removal = longer survival
• Immediate molecular diagnosis = faster treatment decisions
• Real-time genetics = instant clinical trial matching
Right now, fewer than 10% of glioma patients join clinical trials. Why? By the time genetic results come back, the window has closed.
This changes everything.
We’re not just detecting cancer faster. We’re giving surgeons superpowers, patients hope, and families time.
The same team built Prima, another AI reading brain MRIs in seconds with 97.5% accuracy across 52 diagnoses. Strokes, tumors, bleeds, all prioritized instantly.
This is what happens when we stop treating AI as a threat and start using it as a tool.
Every neurosurgeon should have this. Every brain tumor patient deserves this.
Because 90 seconds shouldn’t determine whether someone lives or dies.
But today, it might save their life.
♻️ Repost if every brain tumor patient deserves real-time genetic diagnosis
👉 Follow me, Jonathan Govette, for daily, real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
